The Saudi Arabia in-vitro diagnostics (IVD) market reached a value of US$ 760 Million in 2020.
Saudi Arabia currently represents the largest market for in-vitro diagnostics in the GCC region. In-vitro diagnostics, plays a significant role in in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, which enables improved monitoring and treatment. Diagnostics represent only a small share of the total healthcare spending but are critical in medical decision making and reducing the burden of diseases and healthcare expenditures.
There has been a steady growth in the adoption of in-vitro diagnostics in Saudi Arabia. Increasing incidence rates of various infectious and chronic diseases represent some of the key drivers of the in-vitro diagnostics market in Saudi Arabia. The country’s population is currently around 33 Million and is growing annually at around 2%. According to Saudi Arabia’s General Authority of Statistics, elderly constituted 4.2% of the total Saudi population and are expected to increase further in the coming years. With an increasing elderly population, we expect the prevalence of a number of chronic diseases to increase significantly in the next few years. Moreover, catalyzed by rising physical inactivity and consumption of unhealthy diets, the prevalence of a number of lifestyle diseases have been increasing in the country. Saudi Arabia has one of the highest rates of obesity in the world. It is estimated that around 36% of the total population are obese. Additionally, the prevalence of hypertension was around 29% among males and around 24% among females. Saudi Arabia also has one of the highest prevalence of diabetes with around 19% of the adult population suffering from diabetes in the country. Some of the other factors catalyzing the growth of in-vitro diagnostics in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc. Looking forward, the analyst expects the Saudi Arabia in-vitro diagnostics (IVD) market to exhibit moderate growth during 2021-2026.
Report Summary
Breakup by Application: On the basis of application, the market has been segmented into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases and others.
Breakup by End-User: Based on end-user, the report finds that hospital-based centers currently represent the leading end-user of in-vitro diagnostics in Saudi Arabia. Hospital-based centers are followed by diagnostic chains, standalone centers and others (patient self-testing, academic institutes, etc.)
Competitive Landscape: The report also provides the competitive landscape and the profiles of key players operating in this market.
This report provides a deep insight into the Saudi Arabia in-vitro diagnostics (IVD) devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Saudi Arabia in-vitro diagnostics (IVD) market in any manner.
Key Questions Answered in This Report: How has the Saudi Arabia in-vitro diagnostics (IVD) market performed so far and how will it perform in the coming years? What are the key application segments in the Saudi Arabia in-vitro diagnostics (IVD) market? What has been the impact of COVID-19 on the Saudi Arabia in-vitro diagnostics (IVD) market? What are the major end-users in the Saudi Arabia in-vitro diagnostics (IVD) market? What are the various stages in the value chain of the Saudi Arabia in-vitro diagnostics (IVD) market? What are the key driving factors and challenges in the Saudi Arabia in-vitro diagnostics (IVD) market? What is the degree of competition in the Saudi Arabia in-vitro diagnostics (IVD) market?
Our reports have been used by over 10K customers, including:
The global IVD contract research organization market is expected to grow from US$ 4,738.79 million in 2021 to US$ 8,019.53 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. The rising prevalence of infectious diseases increases the demand for IVD and clinical trials along with new product launches, which...
China In-Vitro Diagnostics (IVD) market is predicted to reach US$ 21 Billion by 2028. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. Historically, large multinational companies have dominated IVD market in China; today, domestic companies...
The in vitro diagnostics market was valued at approximately USD 76,281.75 million in 2021, and it is expected to witness a revenue of USD 1,01,542.35 million in 2027, with a CAGR of 4.90% over the forecast period. The COVID-19 pandemic turned the spotlight on in vitro diagnostics since there is an increasing demand for IVD kits and...
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...
250 pages •
By The Business Research Company
• May 2022
Major companies in the in-vitro diagnostics devices and equipment market include Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc, and Thermo Fisher Scientific Inc. The global in-vitro diagnostics market is expected to grow from $83.64 billion in 2021 to $96.49 billion in 2022 at...
The Global In Vitro Diagnostics Partnering Terms and Agreements 2010-2022 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This...
2022 France In Vitro Diagnostics Market Analysis and Forecasts for 500 Tests: Supplier Shares by Test, Segmentation Forecasts, Competitive Intelligence, Technology Trends, Emerging Opportunities This new report provides an overview of the French diagnostic testing market, including sales and market shares of leading...
2022 Germany In Vitro Diagnostics Market Analysis and Forecasts for 500 Tests: Supplier Shares by Test, Segmentation Forecasts, Competitive Intelligence, Technology Trends, Emerging Opportunities This new report provides an overview of the German diagnostic testing market, including sales and market shares of leading...
2022 Italy In Vitro Diagnostics Market Analysis and Forecasts for 500 Tests: Supplier Shares by Test, Segmentation Forecasts, Competitive Intelligence, Technology Trends, Emerging Opportunities This new report provides an overview of the Italian diagnostic testing market, including sales and market shares of leading...
Diagnostics
In Vitro Diagnostics
Blood Supply
Italy
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.